Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17513813

J. Clin. Oncol. 2007 May 20 25 15 2078-85

Download in:

View as

General Info

PMID
17513813